|
Tanya Parish, PhD
Vice President, Drug Discovery
Tanya Parish is the Vice President of Drug Discovery at IDRI.
Her work focuses on the discovery of new drugs, particularly for tuberculosis and includes drug target identification and validation, assay development and high throughput screening, and synthetic and medicinal chemistry.
Work in her groups covers a number of areas of biology and chemistry and includes:
- The investigation of essential cellular processes in mycobacteria
- The mode of action of antibiotics
- Enzyme characterization and assay development
- High throughput screening (biochemical and whole cell assays)
- Optimization of new drug candidates
- Method development
Tanya has edited five books on mycobacteria
and published numerous papers on the basic biology and
genetics of M. tuberculosis. She is an Editor of Microbiology
(UK), on the Editorial Board for PLoS One and Frontiers in Cell and Infection Microbiology, and a member of the Acid Fast Club for which she
previously served as the (Hon) Secretary. Tanya is also an
Affiliate Professor in the Department of Global Health at the
University of Washington.
Tanya
has expertise in the molecular genetics and the microbiology
of mycobacteria. She received her PhD at the National Institute for Medical
Research with Philip Draper, where she investigated gene
regulation in mycobacteria. She subsequently conducted
postdoctoral research at the London School of Hygiene &
Tropical Medicine with Neil Stoker, studying several facets of
the biology of M. tuberculosis. In 2000, Tanya took up an academic post as Professor of Mycobacteriology at Barts and the London School of Medicine and Dentistry at Queen Mary, University of London. She still maintains an active research group in london, investigating the biology and pathogenesis of M. tuberculosis.
| 
